VarCT Diagnostics CEO, Dr. Ali Salanti, receives the preclinical Kirsten & Freddy Johansen Foundation (KFJ) Award for his life-long contribution to research. With the Award comes 2M DKK to continue …
Through a Distinguished Innovator grant from Novo Foundation to VAR2 Pharma collaborator, University of Copenhagen, the ofCS antibody program has been awarded 1M euro to finalize the preclinical development of …
VarCT Diagnostics co-authors have published new work on how the VarCT Diagnostics’ rVAR2 proteins are internalized into tumor cells after binding to cell surface proteoglycans. The cell surface proteoglycan composition …